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Abstract
Engineered model substrates are powerful tools for examining interactions between stem cells and their microenvironment.
Using this approach, we have previously shown that restricted cell adhesion promotes terminal differentiation of human
epidermal stem cells via activation of serum response factor (SRF) and transcription of AP-1 genes. Here we investigate the
roles of p38 MAPK and histone acetylation. Inhibition of p38 activity impaired SRF transcriptional activity and shape-induced
terminal differentiation of human keratinocytes. In addition, inhibiting p38 reduced histone H3 acetylation at the promoters
of SRF target genes, FOS and JUNB. Although histone acetylation correlated with SRF transcriptional activity and target gene
expression, treatment with the histone de-acetylase inhibitor, trichostatin A (TSA) blocked terminal differentiation on micro-
patterned substrates and in suspension. TSA treatment simultaneously maintained expression of LRIG1, TP63, and ITGB1.
Therefore, global histone de-acetylation represses stem cell maintenance genes independent of SRF. Our studies establish a
novel role for extrinsic physical cues in the regulation of chromatin remodeling, transcription, and differentiation of human
epidermal stem cells.
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Introduction
Cell-extracellular matrix (ECM) interactions are key regulators
of epidermal stem cell fate. Epidermal stem cells express high
levels of b1 [1,2] and a6 [3] integrins, and integrin-mediated
adhesion to the basement membrane maintains keratinocytes in an
undifferentiated state [4]. In vitro, loss of adhesion to the ECM
rapidly induces epidermal terminal differentiation [5]. We recently
developed novel micro-patterned substrates on which ECM
proteins are deposited in defined shapes and areas [6,7]. Using
this system to precisely control the level of adhesion and spreading
of single cells, we demonstrated that limited cell adhesion
promotes cortical actin polymerization and terminal differentia-
tion in human epidermal stem cells. Downstream of actin
polymerization, differentiation is regulated by serum response
factor (SRF) and AP-1 transcription factors. The SRF signaling
pathway therefore links extrinsic physical cues to a transcriptional
mechanism for controlling cell fate within the epidermis [6,8,9].
SRF is a transcription factor expressed in many tissues, and its
activity is modulated by interactions with various co-factors,
including myocardin-related transcription factor-A (MRTF-A; also
known as MAL, MKL1) [10]. Monomeric (G-) actin binds
MRTF-A and inhibits nuclear accumulation and activation of
SRF. F-actin polymerization releases MRTF-A to enter the
nucleus and co-activate transcription with SRF [10,11]. SRF
targets include several adhesion-related genes (ACTB, VCL) and
immediate early genes (FOS, JUNB, EGR1) [11,12]. In addition to
actin polymerization, SRF can be activated by the mitogen
activated protein kinase (MAPK), extracellular signal-related
kinase (ERK) [13]. This pathway stimulates a distinct set of co-
factors, which for some genes antagonize MRTF-A interactions
with SRF [14,15]. Thus, specific SRF target genes exhibit
differential sensitivity to cytoskeletal organization and MRTF-A
activation.
Several recent reports demonstrate that epigenetic changes in
chromatin remodeling can have a profound effect on epidermal
development and homeostasis. Polycomb repressive complexes
(PRCs) silence both senescence and terminal differentiation genes
by tri-methylating lysine 27 of histone H3 (triMeK27-H3) [16].
This specific mark aids chromatin packing and limits transcription
[17]. In contrast, histone tail acetylation promotes an open
chromatin structure and allows transcription factors to more easily
access the DNA [17]. Histone deacetylases (HDAC) 1 and 2 are
required for normal terminal differentiation and repression of
p16/Ink4a in the developing mouse epidermis [18]. In adult
epidermis, histone acetylation also promotes exit from the hair
follicle stem cell compartment, and epidermal stem cells display
hypo-acetylated H3 and H4 [18,19]. While it is clear that
chromatin remodeling plays an important role in epidermal
homeostasis, little is known about the upstream or extrinsic signals
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27259that control the activation and specificity of chromatin remodeling
complexes.
In the present study, we sought to determine whether the
physical regulation of human keratinocyte differentiation depends
on intrinsic signaling pathways in addition to actin polymerization.
Since SRF activity is sensitive to both cytoskeletal organization
and MAPK signaling, we examined how various MAP kinases
influence terminal differentiation using micro-patterned substrates
and whether chromatin modification is involved.
Results
p38 signaling is required for shape-induced
differentiation
To investigate the role of MAP kinase signaling in shape-
induced terminal differentiation, primary human keratinocytes
were seeded onto 20 mmo r5 0 mm diameter collagen-coated
circular islands. Cells were cultured on the substrates for 24 h in
the presence or absence of p38, JNK, and ERK inhibitors.
Consistent with our previous findings [6], cells on 20 mm islands
were unable to spread and approximately 50% initiated expression
of the terminal differentiation marker, involucrin, whereas fewer
than 10% of cells on 50 mm islands expressed involucrin (Fig. 1A,
B).
Treatment with both p38 inhibitors, PD169316 and SB202190,
significantly reduced the number of involucrin positive cells, but
inhibiting ERK activity with PD98059 did not affect involucrin
expression (Fig. 1A, B). Similarly, we observed no effect of the
MEK inhibitor, U0126, on shape-induced differentiation [6]. The
decrease in the absolute number of involucrin-positive cells in the
presence of the JNK inhibitor, SP600125, was not statistically
significant (Fig. 1A–B); however, when normalized to involucrin
expression in carrier-treated cells there was a small but significant
reduction (Fig. 1C). Inhibition of p38 MAPK not only inhibited
Figure 1. Effect of MAPK inhibitors on shape-induced terminal differentiation. (A) Representative images of keratinocytes on micro-
patterned substrates comprising 20 mm diameter collagen islands. Cells were cultured for 24 h in medium containing carrier (0.1% DMSO), 10 mM
PD169316, 2 mM SB202190, 10 mM SP600125, or 10 mM PD98059. Immunofluorescence staining for involucrin (green) shows terminally differentiating
cells, and nuclei are labeled with DAPI (blue). Scale bar =50 mm. Quantification of (B-C) involucrin, (D) transglutaminase I, and (E) Ki67 positive cells
after 24 h on 20 mmo r5 0mm substrates. In (C), the proportion of involucrin positive cells was normalized to carrier-treated cells on 20 mm islands.
Data are means 6 SEM of 3 experiments. *P,0.05 compared to carrier.
doi:10.1371/journal.pone.0027259.g001
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PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e27259Figure 2. Effect of p38 inhibition on SRF signaling. (A) SRF transcriptional activity in human keratinocytes expressing the SRF luciferase
reporter and TK renilla control. Cells were treated overnight with 2 mM SB202190 or carrier, then 1 mM cytochalasin D or carrier for 7 h. Data are
means 6 SEM of 4 replicates from one experiment (representative of 3 independent experiments). *P,0.05 compared to carrier. (B) ChIP for SRF
following 24 h treatment with 2 mM SB202190. SRE regulatory elements in the FOS and JUNB genes were detected by real-time RT-PCR, and the
centromeric region of chromosome 11 (SATCEN11) was used as a negative control. Enrichment of the anti-SRF IP is compared to anti-FLAG control,
then normalized to FOS carrier condition. Data are means 6 SEM of 3 experiments. *P,0.05 compared to carrier. (C) Expression of endogenous SRF
target genes measured by real-time RT-PCR. Cells were serum-starved overnight with or without 2 mM SB202190, then stimulated with 10% FBS-
containing medium for 24 h 62 mM SB202190. Data are means 6 SEM of 3 experiments. (D) Expression of endogenous FOS and JUNB on micro-
p38 Regulation of Epidermal Differentiation
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of transglutaminase I (Fig. 1D). We previously showed that cell
shape-induced differentiation is independent of inhibition of
proliferation [6,20]; consistent with those results, p38 inhibition
did not affect the proportion of Ki67 positive cells (Fig. 1E). We
conclude that p38 activity is required for shape-induced
differentiation in human keratinocytes.
p38 mediates SRF transcriptional activity
Since SRF promotes keratinocyte terminal differentiation in
response to restricted adhesion, we investigated whether p38
inhibition influenced SRF signaling. SB202190 treatment of
keratinocytes on non-patterned surfaces significantly inhibited
SRF reporter activity in dual luciferase assays (Fig. 2A) and
reduced the amount of SRF bound to the promoters of the SRF
target genes, FOS and JUNB (Fig. 2B). To understand how p38
regulates the expression of endogenous SRF target genes,
keratinocytes were serum starved overnight in the presence or
absence of SB202190, then stimulated with 10% FBS-containing
medium for 24 h. Under control conditions, each of the SRF
target genes, FOS, JUNB, EGR1, and CTGF, peaked at 1 h
following stimulation (Fig. 2C). Despite reducing SRF binding to
the FOS promoter, treatment with SB202190 had no effect on FOS
expression (Fig. 2C). SB202190 delayed the activation of JUNB
and CTGF (Fig. 2C). While the kinetics of EGR1 activation were
unaffected by p38 inhibition, the peak level increased significantly
(Fig. 2C).
We also examined expression of AP-1 and stem cell regulatory
genes during shape induced differentiation on the micro-patterned
substrates. When keratinocytes were cultured on 20 mm islands,
SB202190 treatment had little effect on FOS expression; however,
p38 inhibition reduced JUNB activation by approximately 50% at
4 and 24 hours after seeding (Fig. 2D). The stem cell markers
LRIG1 [21], DLL1 [22], and TP63 [23] were all down regulated
24 hours after seeding onto 20 mm islands, and inhibition of p38
had little effect on expression of these genes (Fig. 3A–C). Given
that ITGB1 is a direct SRF target [24], it is interesting to note that
ITGB1 levels were maintained over 24 hours, with or without
patterned substrates. Cells were seeded onto 20 mm islands and allowed to adhere for 1 h before rinsing and treating with carrier or 2 mM SB202190
for an addition 23 h.
doi:10.1371/journal.pone.0027259.g002
Figure 3. Effect of p38 inhibition on epidermal stem cell gene expression. Real-time RT-PCR detection of (A) LRIG1, (B) TP63, (C) DLL1, and
(D) ITGB1 mRNA levels for cells on micro-patterned substrates. Cells were seeded onto 20 mm islands and allowed to adhere for 1 h before rinsing and
treating with carrier or 2 mM SB202190. Expression levels were normalized to the 1 h time point and represent the means 6 SEM of 3 experiments.
doi:10.1371/journal.pone.0027259.g003
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during shape-induced differentiation, p38 specifically regulates
JUNB, but not the stem cell markers LRIG1, DLL1, and TP63.
The SRF target genes that were affected by SB202190, JUNB
and CTGF, are both regulated by the actin cytoskeleton and
MRTF-A [25]. We therefore investigated whether p38 signaling
directly affected cytoskeletal organization and MRTF-A localiza-
tion. On non-patterned surfaces, inhibition of p38 activity with
SB202190 did not alter the formation of paxillin containing focal
adhesions or the assembly of F-actin fibers (Fig. 4A). Furthermore,
MRTF-A nuclear translocation in response to cytochalsin D
treatment [6] was not affected by p38 inhibition (Fig. 4B). These
results suggest that p38 influences transcription via altered
interactions between SRF and MRTF-A inside the nucleus.
Histone acetylation influences SRF transcriptional activity
and is regulated by p38
Global changes in histone acetylation influence epidermal stem
cell self-renewal and terminal differentiation [18], and p38 has
recently been linked to SRF signaling and histone acetylation [26].
We therefore examined the effect of histone acetylation on SRF
transcriptional activity in human keratinocytes. Treatment for
24 h with the histone de-acetylase inhibitor, trichostatin A (TSA)
significantly enhanced SRF transcriptional activity in luciferase
assays (Fig. 5A). Similarly, we observed a 1.5–2 fold increase in
FOS, EGR1, and JUNB expression following TSA exposure
(Fig. 5B). Cytoskeletal disruption with cytochalasin D or p38
inhibition with SB202190 had little effect on global histone
acetylation (Fig. 5C). However, SB202190 treatment specifically
reduced histone acetylation at the FOS and JUNB promoters
(Fig. 5D). Based on these results, we conclude that histone
acetylation promotes SRF transcriptional activity and is mediated
by p38 signaling.
Global histone de-acetylation is required for shape-
induced differentiation
To directly determine the effects of restricted adhesion on
histone acetylation we next examined global H3 and H4
acetylation by immunofluorescence labeling of cells on micro-
patterned substrates. We observed a significant reduction in the
number of keratinocytes with hyper-acetylated H3 and H4 on the
20 mm islands compared to the 50 mm islands (Fig. 6A, B). In
addition, TSA treatment completely blocked shape-induced
involucrin expression on 20 mm islands (Fig. 6C). We conclude
that restricted adhesion leads to global histone de-acetylation and
this chromatin modification is required for terminal differentia-
tion.
The inhibitory effects of TSA on involucrin expression were
surprising given that it also stimulated FOS and JUNB gene
expression, which are required for terminal differentiation. We
hypothesized that up-stream regulatory genes were also activated
by histone acetylation to suppress differentiation. We therefore
examined the effect of TSA on LRIG1, TP63, and ITGB1. When
keratinocytes were disaggregated and placed in suspension,
mRNA levels of the differentiation markers involucrin (IVL) and
transglutaminase I (TGM1) were significantly upregulated after
24 h (Fig. 7A, B). This response was completely blocked by TSA,
consistent with the effects of TSA on cells on micro-patterned
substrates. During suspension-induced differentiation LRIG1,
TP63, and ITGB1 mRNAs were down-regulated in untreated
cells; however, TSA treatment maintained expression of these
genes at nearly 0 h levels (Fig. 7C–E). These findings suggest that
histone deacetylation in human keratinocytes is required to repress
stem cell genes during terminal differentiation.
Discussion
Our study demonstrates that keratinocyte terminal differentia-
tion requires a coordinated program of histone acetylation and de-
acetylation (Fig. 7F). Histone acetylation enhances SRF transcrip-
tional activity and expression of AP-1 factors, which are required
for differentiation, and this response is mediated by p38 MAPK.
At the same time, we observe a global reduction in histone
acetylation upon shape-induced differentiation. Inhibiting HDACs
completely blocked involucrin expression while maintaining
expression of known markers of epidermal stem cells. Further-
more, p38 inhibition did not affect LRGI1, DLL1,o rTP63
expression and reduced SRF transcriptional activity even in the
presence of TSA. Histone acetylation therefore appears to play a
dual role in gene silencing and activation during terminal
differentiation and is regulated by at least two independent
pathways.
Cellular stresses, such as ultra-violet light [27] or loss of
adhesion [28], can stimulate p38 phosphorylation in human
keratinocytes. Consistent with our findings, several reports
describe a role for p38 in keratinocyte terminal differentiation
[29,30]. While the SB202190 compound only targets the a and b
Figure 4. Effect of p38 inhibition on cytoskeletal organization
and MRTF-A localization. (A) Representative images of paxillin
(green) and F-actin (red) localization in keratinocytes treated with
carrier or 2 mM SB202190 for 24 h. Scale bar =20 mm (B) Representative
image of MRTF-A localization in keratinocytes transfected with FLAG-
MRTF-A construct, treated overnight with or without SB202190 and
then stimulated with 1 mM cytochalasin D for 1 h. MRTF-A was detected
by immunofluorescence staining for the FLAG tag. N=20 cells
examined per condition. Scale bar =50 mm.
doi:10.1371/journal.pone.0027259.g004
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responsible for regulating involucrin expression [9]. It will be
interesting to explore the specific role of each isoform in SRF
signaling and histone acetylation in future studies.
The SRF target genes we examined displayed differential
sensitivity to p38 inhibition during serum-stimulation and
restricted adhesion. While serum stimulation of JUNB and CTGF
was delayed by SB202190, FOS was unaffected and EGR1 actually
increased. Similarly, JUNB but not FOS was inhibited by
SB202190 on the micro-patterned substrates. It is interesting to
note that p38 inhibition had a greater effect on JUNB expression
on the patterned substrates compared to serum stimulation. It has
also been reported that p38 mediates FOS expression in response
to UVB exposure, but not in response to serum stimulation [31].
These context dependent differences in gene regulation highlight
how specific stimuli can activate AP-1 expression by different
pathways and the complexity of their regulatory mechanisms.
In a recent study, p38 stimulated expression of the SRF target
gene CCN1 via the histone acetyl transferase activity of CREB
binding protein (CBP) [26]. Genome wide analyses have also
mapped CBP bindings sites to SRF and AP-1 genes [32]. Thus,
CBP may connect p38 activity with histone acetylation of SRF
target genes. Interestingly, the CBP homolog p300 is required for
keratinocyte terminal differentiation and influences p21 expression
by histone acetylation; however, this response is not affected by
CBP knockdown [32]. While it is clear from our studies and others
that CBP and p300 play important roles in histone acetylation and
keratinocyte differentiation, further work is needed to elucidate
their specific functions and regulatory mechanisms.
In the present study we employed micro-patterned substrates to
manipulate keratinocyte shape and adhesion. While this system
has the advantage of precisely controlling single cell behavior, it is
by nature highly synthetic and in some cases not representative of
the in vivo situation. For example, we observe a direct transition
from stem cells to terminal differentiated keratinocytes while
maintaining adhesion to a basal ECM. In contrast, cells in vivo
lose contact to the basement membrane before turning on late
terminal differentiation markers, such as involucrin. While it is
important to keep these differences in mind when interpreting the
results of our studies, this model system has allowed us to identified
SRF as a key regulator of terminal differentiation [6]. This result
has been corroborated by two different mouse models [8,33] and
demonstrates that our approach can provide new and physiolog-
ically relevant insights into keratinocyte terminal differentiation.
Histone acetylation regulates the differentiation and self-renewal
of multiple types of stem cells. In embryonic stem cells, the
Figure 5. Role of histone acetylation in SRF signaling. (A) SRF transcriptional activity in human keratinocytes expressing the SRF luciferase
reporter and TK renilla control. Cells were treated overnight with or without 2 mM SB202190 or 200 nM TSA, then stimulated for 7 h with 10% FBS.
Data are means 6 SEM of 4 replicates from one experiment (representative of 3 independent experiments). *P,0.05 for effect of SB202190, +P,0.05
for effect of TSA. (B) Expression of endogenous SRF target genes measured by real-time RT-PCR. Cells were serum-starved overnight with or without
200 nM TSA, then stimulated with 10% FBS-containing medium for 1 h. Data are means 6 SEM of 3 experiments. *P,0.05 compared to carrier.
(C) Western blot of total and acetylated histone H3 in cells after 24 h treatment with carrier, 1 mM cytochalasin D, 2 mM SB202190, or 200 nM TSA.
(D) ChIP of acetylated H3 in cells following 24 h treatment with 2 mM SB202190. DNA sequence flanking the SRE regulatory elements in the FOS and
JUNB genes were detected by real-time RT-PCR, and the centromeric region of chromosome 11 (SATCEN11) was used as a negative control.
Enrichment from the anti-AcH3 IP is reported relative to anti-FLAG control.
doi:10.1371/journal.pone.0027259.g005
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required for maintaining pluripotency [34], and loss of HDAC1
causes spontaneous differentiation along cardiac and neuronal
lineages [35]. In contrast, deletion of HDAC 1 and 2 in mice
inhibits the differentiation of neural pre-cursers into differentiated
neural lineages [36]. These findings indicate that the role of histone
acetylation in differentiation depends on the specific cell type and
stage of development. Interestingly, Myc-stimulated differentiation
in the mouse epidermis is associated with histone acetylation [19],
yet deletion of HDAC1 and 2 in vivo [18] or TSA treatment in our
in vitro model blocks terminal differentiation. Together, these
findings further suggest that histone acetylation has distinct effects
on cell behavior at different stages of epidermal differentiation.
Although the functions of several chromatin remodeling
complexes have been described in the skin [16,18], we still know
very little about the upstream signals governing their activity. Cell
rounding has previously been shown to promote global histone de-
acetylation in mammary epithelial cells [37] and tensile stretching
can stimulate CBP acetyl-transferase activity in fibroblasts [26].
Our work is the first to implicate extrinsic physical cues in
regulating chromatin modifications that are essential for stem cell
differentiation. The mechano-transduction mechanisms leading to
chromatin remodeling are likely to be important regulators of
transcription during other physical processes, including wound
healing, neuronal out-growth, and tumor invasion.
Materials and Methods
Generation of micro-patterned, polymer brush substrates
Patterned poly-oligo(ethylene glycol methacrylate) (POEGMA)
brushes were generated as previously described [6,7,38]. Briefly,
master silicon molds were created by photolithography and used to
Figure 6. Role of global histone acetylation in shape-induced differentiation. (A) Representative immuno-fluorescence images of
acetylated H3 (Ac-H3) and H4 (Ac-H4) in cells after 24 h on micro-patterned substrates containing 20 mmo r5 0 mm diameter islands. (B)
Quantification of Ac-H3 and Ac-H4 on patterned substrates. Data are means 6 SEM of 3 experiments. *P,0.05 compared to 50 mm islands. (C)
Quantification of involucrin positive cells 24 h after plating on patterned substrates and treatment with carrier or 200 nM TSA. Data are means 6 SEM
of 3 experiments. *P,0.05 compared to carrier.
doi:10.1371/journal.pone.0027259.g006
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stamps were inked with the thiol initiator, v-mercaptoundecyl
bromoisobutyrate, and brought into conformal contact with gold-
coated coverslips to deposit the initiator as a self-assembled
monolayer. Atom transfer radical polymerisation (ATRP) of oligo
ethylene glycol methacrylate (MW 300) was carried out in a
water/ethanol (4:1) solution of OEGMA (1.6 M), Cu(II)Br2
(3.3 mM), bipyridine (82 mM), and Cu(I)Cl (33 mM). The
reaction was performed at room temperature for 15 minutes,
resulting in an estimated 20 nm thick brush. The patterned
substrates were rinsed with water and ethanol, dried, and stored
under N2. Immediately before cell seeding, patterned substrates
were coated with 20 mg/ml of rat type I collagen (BD Biosciences)
in phosphate-buffered saline (PBS) for 1 h at 37uC. Substrates
were rinsed three times with 1 mM HCl and twice with PBS.
Culture of primary human keratinocytes
Primary human keratinocytes were isolated from neonatal
foreskin. All the cells used in this study were obtained prior to the
Human Tissue Act 2006, and the patients were kept anonymous.
Keratinocytes (KY strain passage 2–8) were cultivated on a feeder
layer of J2 3T3 fibroblasts as previously described [39]. Following
Figure 7. Effect of TSA on suspension-induced differentiation. Keratinocytes were cultured for 24 h in 1% methylcellulose with or without
200 nM TSA. Expression of (A) IVL, (B) TGM1, (C) LRIG1, (D) TP63, and ITGB1 mRNA levels were measured by real-time RT-PCR at 0, 4, and 24 h. Data are
means 6 SEM of 3 experiments. *P,0.05 compared to carrier. (E) Proposed model for the role of histone acetylation during shape-induced terminal
differentiation of human keratinocytes.
doi:10.1371/journal.pone.0027259.g007
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seeded onto the micro-patterned substrates at a density of 25,000/
cm
2 in complete FAD (1 part Ham’s F12, 3 parts DMEM, 10
24 M
adenine, 10% FBS, 0.5 mg/ml hydrocortisone, 5 mg/ml insulin,
10
210 M cholera toxin, 10 ng/ml EGF) medium. Cells were
allowed to adhere for 1 h and rinsed three times with fresh
medium. For some experiments, inhibitor supplemented medium
was added at the indicated dose immediately after rinsing. For
suspension culture experiments, keratinocytes were resuspended in
complete FAD supplemented with 1% methylcellulose and
cultured for to 24 h before recovery by centrifugation.
Antibodies and inhibitors
Rabbit anti-Ki67 was purchased from Abcam (Cambridge, UK).
Mouse anti-involucrin (SY5), and mouse anti-transglutaminase I
(BC1) were prepared by Cancer Research UK central services.
Rabbit anti-AcH3, anti-AcH4, and anti-total H3 were purchased
from Millipore,. Cytochalasin D, PD98059, PD169316, SB202190
and SP600125 were obtained from Calbiochem (La Jolla, CA), and
Trichostatin A was from Sigma Aldrich (St. Louis, MO).
Transfections and luciferase assays
Keratinocytes were cultured in KSFM (Gibco) on collagen-coated
dishes for 24 h prior to transfection. Cells were transfected for 3 h
using 1 ml Lipofectamine 2000 (Invitrogen) and 1 mgo fD N Ap e r1 0
5
cells. The FLAG-MAL and SRF reporter (p3DA.luc) constructs were
kindly provided by Richard Treisman and have been described
previously [10]. Thymidine kinase (TK) driven Renillawas used as an
internal control and transfected 1:1 with p3DA.luc. Following DNA
transfection, cells were rinsed and cultured for 24 to 48 h before
treating with FBS or inhibitors. Luciferase assays were carried out in
24-well plates (n=4 wells). Cells were treated for 7 h with FBS and
the indicated doses of inhibitors, then harvested and analyzed using
the dual luciferase assay (Promega). SRF activity was reported relative
to thymidine kinase levels, except in the TSA experiments. In this
case, TSA significantly affected the control reporter and only raw
SRF activity was reported.
Immunofluorescence staining and quantification
Cultured cells were fixed in 4% PFA for 10 minutes and
permeabilized with 0.2% Triton-X100 for 5 minutes at room
temperature. Samples were blocked for 1 h in 10% FBS plus
0.25% gelatin, incubated with primary antibodies for 1 h at room
temperature or overnight at 4uC, and incubated with Alexafluor
(488 and 555)-conjugated secondary antibodies for 1 h at room
temperature. TRITC-phalloidin and DAPI were included in the
secondary antibody solution where indicated. Fixed and stained
coverslips were mounted on glass slides with Mowiol reagent, and
images were acquired with a Leica DMI4000 fluorescence
microscope or Leica TCS SP5 confocal microscope. For scoring
involucrin, transglutaminase 1, and AcH3/4 expression at least 6
fluorescence images were taken per condition (approximately 50
cells) per experiment and analyzed with Image J software. Cells
with intensities above background levels (normal mouse serum)
were scored as positive.
Western blotting
Keratinocytes were lysed in ice cold RIPA buffer with protease
inhibitor tablets (Roche). Insoluble material was removed by
centrifugation, and the supernatent was diluted with a loading
buffer (Invitrogen) containing 1% 2-Mercaptoethanol. Equal
amounts of lysate were separated by SDS-PAGE on a 4–12%
gradient gel (Invitrogen), and transferred to PVDF membranes.
Membranes were blocked with 5% non-fat dry milk, and
incubated overnight with primary antibodies for Ac-H3 (1:1000)
or total H3 (1:1000). Secondary detection was performed with a
HRP-conjugated anti-rabbit antibody (1:5000) at room tempera-
ture for 1 h. Blots were treated with ECL reagent (GE Healthcare)
for 1 min and developed on X-ray film.
Chromatin immunoprecipitation
Chromatin immunoprecipitation was performed as described
previously [6]. Keratinocytes (10
7) were cultured overnight in
KSFM with or without inhibitors and fixed with 1% PFA for
10 min. Chromatin was sonicated to an average length of 1 kb,
incubated overnight with 10 mg of anti-FLAG, anti-SRF, or anti-
AcH3 antibodies at 4uC, and precipitated with G-protein coupled
Dynabeads (Invitrogen) for 4 h at 4uC. Cross-links were reversed
by incubating at 65uC overnight, and DNA was isolated with a
PCR purification kit (Qiagen). Quantitative RT-PCR was
performed with Sybr Green (Sigma) and custom primers for
regions around JUNB, FOS, SATCEN11. Data are reported as the
fold enrichment compared to the anti-FLAG control.
Real-time RT-PCR
Total RNA was isolated using a Purelink RNA kit (Invitrogen)
and reverse transcribed to cDNA using a Superscript III kit
(Invitrogen). PCR reactions were carried out with Taqman Gene
Expression Assays for FOS, JUNB, CTGF, EGR1, IVL, TGM1,
LRIG1, DLL1, TP63, and ITGB1 (Applied Biosystems), and all data
were normalized to GAPDH or 18S expression.
Statistical Analyses
All data were analyzed by one or two factor ANOVA and Tukey’s
test for posthoc analysis. Significance was determined by P,0.05.
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